---
figid: PMC7864210__cancers-13-00369-g001
figlink: pmc/articles/PMC7864210/figure/cancers-13-00369-f001/
number: Figure 1
caption: ERα:E2 signaling network and crosstalk with growth factor signaling. (A)
  Schematic view of classic genomic ERα:E2 signaling involving passive diffusion of
  E2 into cytoplasm and nucleus and activation of ERα signaling. (B) Growth factors
  activate receptor tyrosine kinases, which activate MAPKs. MAPKs can then phosphorylate
  and activate ERα either independent of E2 or synergize with E2 for optimal ERα activation.
  (C) Membrane associated ERα interacts and activates SRC kinase upon ligand binding.
  SRC kinase then phosphorylates and activates aromatase, which catalyzes conversion
  of androgens to estrogens within cells and amplify both genomic and nongenomic ERα-E2
  signaling. (D) Membrane anchored ERα can also activate various cytoplasmic kinases
  including PI3K-AKT-mTOR pathway through nongenomic actions and these actions occur
  rapidly (within five minutes) after encountering the ligand. Activated PI3K-AKT-mTOR
  can enhance genomic actions of ERα (depicted in Figure 3). (E,F) Activated ERα alters
  gene expression in the nucleus through either direct binding to estrogen response
  elements (EREs) in the genome or bind genome by tethering onto other transcription
  factors (TFs) and their response element (RE).
pmcid: PMC7864210
papertitle: Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer.
reftext: Aditi S. Khatpe, et al. Cancers (Basel). 2021 Feb;13(3):369.
pmc_ranked_result_index: '7020'
pathway_score: 0.9758807
filename: cancers-13-00369-g001.jpg
figtitle: ERA:E2 signaling network and crosstalk with growth factor signaling
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7864210__cancers-13-00369-g001.html
  '@type': Dataset
  description: ERα:E2 signaling network and crosstalk with growth factor signaling.
    (A) Schematic view of classic genomic ERα:E2 signaling involving passive diffusion
    of E2 into cytoplasm and nucleus and activation of ERα signaling. (B) Growth factors
    activate receptor tyrosine kinases, which activate MAPKs. MAPKs can then phosphorylate
    and activate ERα either independent of E2 or synergize with E2 for optimal ERα
    activation. (C) Membrane associated ERα interacts and activates SRC kinase upon
    ligand binding. SRC kinase then phosphorylates and activates aromatase, which
    catalyzes conversion of androgens to estrogens within cells and amplify both genomic
    and nongenomic ERα-E2 signaling. (D) Membrane anchored ERα can also activate various
    cytoplasmic kinases including PI3K-AKT-mTOR pathway through nongenomic actions
    and these actions occur rapidly (within five minutes) after encountering the ligand.
    Activated PI3K-AKT-mTOR can enhance genomic actions of ERα (depicted in Figure
    3). (E,F) Activated ERα alters gene expression in the nucleus through either direct
    binding to estrogen response elements (EREs) in the genome or bind genome by tethering
    onto other transcription factors (TFs) and their response element (RE).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - SRC
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - MTOR
  - TF
  - Estrogen
genes:
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
- word: SRC
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
diseases: []
---
